Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology In 21^st Century Cures: Heading Toward A Two-FDA Solution?

Jan 10 2017

• By Michael McCaughan

FDA entrance sign 2016

Related Content

The Real Impact Of ‘Cures’: The Hype Means Something

Dec 15 2016

Podcast: Multiple ‘Centers of Excellence’ At US FDA Could Create Review Inefficiencies – Jenkins

Dec 20 2016

Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?

Nov 28 2016

FDA's Pazdur Won't Become Oncology Bureaucrat: 'My Presence Will Be Felt'

Jun 30 2016

Additional Topics

United States FDA Regulation Review Pathway Cancer BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window